ENTA
Enanta Pharmaceuticals, Inc.
Small-cap specialty pharma focused on viral hepatitis and other infectious diseases with minimal direct government dependence or political engagement.
Govt Dependence
25/100
Regulatory Density
65/100
Lobbying Intensity
5/100
Political Signal
LOW
BusinessWhat ENTA does
Enanta Pharmaceuticals develops and commercializes antiviral therapeutics, primarily for hepatitis C and other infectious diseases. Revenue is driven by product sales and licensing agreements; the company has limited Medicare/Medicaid exposure relative to large-cap pharma.
12 months past · 3 months futureENTA activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
90 trading days ·
0 congressional trades shown
·
0 insider buys
·
9 13F filings
·
2 past bill actions
·
3 upcoming markups
Lifetime Government AwardsENTA federal contracts by year
$21M
total awarded · 2011–2011
1
contracts on file
2011
peak year ($21M)
Top contracts by award amount
$20.6M
Department of Health and Human Serv
2011-09-27
DEVELOPMENT OF THERAPEUTICS FOR BIODEFENSE
1 years · 1 contracts
Smart Money · 13F HoldingsHedge funds holding ENTA
$11.78B
Total ENTA held by tracked 13F funds
4
Funds with ENTA positions
Renaissance Technologies
$8.40B
holds
2026-03-31
Two Sigma Investments
$3.38B
-6%
2026-03-31
D.E. Shaw & Co.
$2M
-56%
2025-12-31
Citadel Advisors
$939K
+124%
2025-12-31
Congressional TradesWho in Congress is trading ENTA
2023-07-12
Daniel S. Goldman
Sale
$1,001 - $15,000
2023-07-12
Daniel S. Goldman
sale
$1,001 - $15,000
2015-05-27
(unknown)
Sale
$1,001 - $15,000
2015-05-27
(unknown)
sale
$1,001 - $15,000
2015-03-20
(unknown)
Purchase
$1,001 - $15,000
2015-03-20
(unknown)
purchase
$1,001 - $15,000
6+ trades on file · most recent 2023-08-13
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting ENTALive legislation impacting this stock
HR.210 · 119th
Dental Care for Veterans Act
HR.109 · 119th
TEAM Veteran Caregivers Act
HR.372 · 119th
Drug Testing for Welfare Recipients Act
HR.290 · 119th
Rural Telehealth and Education Enhancement Act of 2025
HR.220 · 119th
Veterans Infertility Treatment Act of 2025
HR.255 · 119th
To name the Department of Veterans Affairs community-based outpatient clinic in Lubbock, Texas, as the "General Bernie Mittemeyer
HR.71 · 119th
Veterans Health Care Freedom Act
HR.149 · 119th
Lead by Example Act of 2025
HR.211 · 119th
Equal Access to Contraception for Veterans Act
HR.375 · 119th
Continued Rapid Ohia Death Response Act of 2025
Political ProfileWhere ENTA sits in Washington
Enanta has no measurable lobbying footprint, zero politician trades, and minimal campaign engagement. Stock movement is driven by clinical trial results and FDA decisions, not legislative/regulatory news.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA approval delays
- drug pricing pressure
- patent cliff risk
Regulatory opportunities
- orphan drug designation expansion
- accelerated approval pathways
Member intelligence layer
Live signals + predictions for ENTA — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ENTA
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout ENTA & political exposure
Does Enanta Pharmaceuticals, Inc. (ENTA) hold federal contracts?
Yes. Enanta Pharmaceuticals, Inc. has 1 federal contract awards totaling $20,636,844, primarily from agencies including Department of Health and Human Services. See full contract list and amounts on this page.
Has Congress traded ENTA stock?
6 congressional trades by 2 unique members of Congress, most recently on 2023-07-12. See the Congressional Trading panel for politician-by-politician breakdown.
What is ENTA political risk profile?
Government dependence: 25/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track ENTA political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ENTA data is updated daily from these official federal sources.